DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

American Heart Association 

National Center
7272 Greenville Avenue
Dallas  Texas  75231  U.S.A.
Phone: 800-242-8721 Fax:


SEARCH JOBS










 Company News
Ekos Release: Pulmonary Embolism Trial Comparing Endovascular Ultrasound To Standard Of Care Anticoagulation Published In The American Heart Association’s Journal, Circulation 1/20/2014 10:50:06 AM    More...
Humacyte, Inc. Presents Interim First-in-Human Data For Investigational Bioengineered Blood Vessel At American Heart Association Scientific Sessions 2013 11/20/2013 10:40:02 AM    More...
Study Finds That Use Of An Impedance Threshold Device Combined With High Quality CPR And Adherence To American Heart Association Guidelines Increases Neurologically-Intact Survival Rate From In-Hospital Cardiac Arrest To 30 Percent 11/19/2013 9:59:34 AM    More...
Capstone Therapeutics (CAPS) Announces A Lipimetix Development, LLC Presentation At The American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit Of AEM-28 On Established Atherosclerotic Lesions 11/19/2013 9:18:34 AM    More...
Singulex, Inc.’s Assay For Cardiovascular Risk Assessment Highlighted In Two Presentations At American Heart Association 2013 Scientific Sessions 11/19/2013 7:20:32 AM    More...
Celladon Corporation Announces Oral Presentation At American Heart Association Of Long Term Follow-Up Results From The MYDICAR CUPID 1 Trial In Advanced Heart Failure 11/19/2013 6:26:18 AM    More...
Aegerion Pharmaceuticals, Inc. (AEGR) Presents Data From Phase 3 Extension Study Of JUXTAPID™ (Lomitapide) Capsules In Homozygous Familial Hypercholesterolemia (Hofh) At American Heart Association Scientific Sessions 11/18/2013 12:45:46 PM    More...
Boehringer Ingelheim Corporation Release: Data From First Phase I Study Of Antidote For Pradaxa® (dabigatran etexilate mesylate) Presented At American Heart Association Scientific Sessions 11/18/2013 11:17:48 AM    More...
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Long-Term Data Presented At American Heart Association Scientific Sessions Reinforce Safety Profile Of Pradaxa® (dabigatran etexilate mesylate) 11/18/2013 11:14:35 AM    More...
CardioDx, Inc. Release: New Data Presented At The American Heart Association Scientific Sessions Highlight The Clinical Utility Of The Corus CAD Gene Expression Test In Women And Demonstrate That The Corus CAD Score Correlates With Cardiovascular Outcomes 11/18/2013 11:11:50 AM    More...
12345678910...